AesculaTech

AesculaTech Develops AesculaGel, a Gel for Glaucoma Treatment That Does Not Require Daily Use and Can Deliver Medication to the Eye Continuously for 90 Days via Non-Invasive Means, Ensuring Patient Compliance. This Technology Will Eventually Be Developed into an FDA-Approvable Product Through Preclinical Studies and Clinical Trials.